Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Visual Function Questionnaire as an outcome measure for homonymous hemianopia: subscales and supplementary questions, analysis from the VISION trial.

Rowe FJ, Hepworth LR, Conroy EJ, Rainford NEA, Bedson E, Drummond A, García-Fiñana M, Howard C, Pollock A, Shipman T, Dodridge C, Johnson S, Noonan C, Sackley C.

Eye (Lond). 2019 Apr 17. doi: 10.1038/s41433-019-0441-z. [Epub ahead of print]

PMID:
30996338
2.

Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway.

Chen Z, Mo J, Brosseau JP, Shipman T, Wang Y, Liao CP, Cooper JM, Allaway RJ, Gosline SJC, Guinney J, Carroll TJ, Le LQ.

Cancer Discov. 2019 Jan;9(1):114-129. doi: 10.1158/2159-8290.CD-18-0151. Epub 2018 Oct 22.

PMID:
30348677
3.

Choice of outcome measures for the VISION pilot trial of interventions for hemianopia.

Rowe FJ, Conroy EJ, Bedson E, Cwiklinski E, Drummond A, García-Fiñana M, Howard C, Pollock A, Shipman T, Dodridge C, MacIntosh C, Johnson S, Noonan C, Barton G, Sackley C.

Acta Neurol Scand. 2017 Nov;136(5):551-553. doi: 10.1111/ane.12772. No abstract available.

PMID:
28980307
4.

A pilot randomized controlled trial comparing effectiveness of prism glasses, visual search training and standard care in hemianopia.

Rowe FJ, Conroy EJ, Bedson E, Cwiklinski E, Drummond A, García-Fiñana M, Howard C, Pollock A, Shipman T, Dodridge C, MacIntosh C, Johnson S, Noonan C, Barton G, Sackley C.

Acta Neurol Scand. 2017 Oct;136(4):310-321. doi: 10.1111/ane.12725. Epub 2016 Dec 27.

PMID:
28028819
5.

A Randomised Controlled Trial of Treatment for Post-Stroke Homonymous Hemianopia: Screening and Recruitment.

Rowe FJ, Conroy EJ, Barton PG, Bedson E, Cwiklinski E, Dodridge C, Drummond A, Garcia-Finana M, Howard C, Johnson S, MacIntosh C, Noonan CP, Pollock A, Rockliffe J, Sackley CM, Shipman T.

Neuroophthalmology. 2016 Jan 19;40(1):1-7. eCollection 2016 Feb.

6.

Patient reported outcome measures for visual impairment after stroke: a systematic review.

Hepworth LR, Rowe FJ, Harper R, Jarvis K, Shipman T, Rodgers H.

Health Qual Life Outcomes. 2015 Sep 15;13:146. doi: 10.1186/s12955-015-0338-x. Review.

7.

A randomised controlled trial to compare the clinical and cost-effectiveness of prism glasses, visual search training and standard care in patients with hemianopia following stroke: a protocol.

Rowe FJ, Barton PG, Bedson E, Breen R, Conroy EJ, Cwiklinski E, Dodridge C, Drummond A, Garcia-Finana M, Howard C, Johnson S, MacIntosh C, Noonan CP, Pollock A, Rockliffe J, Sackley C, Shipman T; VISION (vision impairment in stroke: intervention or not).

BMJ Open. 2014 Jul 17;4(7):e005885. doi: 10.1136/bmjopen-2014-005885.

8.

Profile of Gaze Dysfunction following Cerebrovascular Accident.

Rowe FJ, Wright D, Brand D, Jackson C, Harrison S, Maan T, Scott C, Vogwell L, Peel S, Akerman N, Dodridge C, Howard C, Shipman T, Sperring U, Macdiarmid S, Freeman C.

ISRN Ophthalmol. 2013 Oct 10;2013:264604. doi: 10.1155/2013/264604. eCollection 2013.

9.

A prospective profile of visual field loss following stroke: prevalence, type, rehabilitation, and outcome.

Rowe FJ, Wright D, Brand D, Jackson C, Harrison S, Maan T, Scott C, Vogwell L, Peel S, Akerman N, Dodridge C, Howard C, Shipman T, Sperring U, Macdiarmid S, Freeman C.

Biomed Res Int. 2013;2013:719096. doi: 10.1155/2013/719096. Epub 2013 Sep 9.

10.

Reading difficulty after stroke: ocular and non ocular causes.

Rowe F, Wright D, Brand D, Jackson C, Price A, Walker L, Harrison S, Eccleston C, Maan T, Scott C, Vogwell L, Peel S, Robson L, Akerman N, Dodridge C, Howard C, Shipman T, Sperring U, Yarde S, Rowe F, Macdiarmid S, Freeman C.

Int J Stroke. 2011 Oct;6(5):404-11. doi: 10.1111/j.1747-4949.2011.00583.x. Epub 2011 Mar 1.

PMID:
21609413
11.

Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.

Le LQ, Liu C, Shipman T, Chen Z, Suter U, Parada LF.

Cancer Res. 2011 Jul 1;71(13):4686-95. doi: 10.1158/0008-5472.CAN-10-4577. Epub 2011 May 6.

12.

Acute v pattern esotropia without abduction deficit, secondary to a posterior fossa pilocytic astrocytoma.

Shipman TL.

J Pediatr Ophthalmol Strabismus. 2009 Jul-Aug;46(4):235-7. doi: 10.3928/01913913-20090706-12. Epub 2009 Mar 20.

PMID:
19645405
13.

Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Le LQ, Shipman T, Burns DK, Parada LF.

Cell Stem Cell. 2009 May 8;4(5):453-63. doi: 10.1016/j.stem.2009.03.017.

14.

Decompensating esophoria as the presenting feature of myasthenia gravis.

Arblaster GE, Shipman TL, Pepper IM.

J AAPOS. 2009 Jun;13(3):310-1. doi: 10.1016/j.jaapos.2009.01.009. Epub 2009 Apr 22.

PMID:
19395293
15.

Visual impairment following stroke: do stroke patients require vision assessment?

Rowe F, Brand D, Jackson CA, Price A, Walker L, Harrison S, Eccleston C, Scott C, Akerman N, Dodridge C, Howard C, Shipman T, Sperring U, MacDiarmid S, Freeman C.

Age Ageing. 2009 Mar;38(2):188-93. doi: 10.1093/ageing/afn230. Epub 2008 Nov 21.

PMID:
19029069
16.

A nuclear surveillance pathway for mRNAs with defective polyadenylation.

Milligan L, Torchet C, Allmang C, Shipman T, Tollervey D.

Mol Cell Biol. 2005 Nov;25(22):9996-10004.

17.

Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators.

Glikson M, Swerdlow CD, Gurevitz OT, Daoud E, Shivkumar K, Wilkoff B, Shipman T, Friedman PA.

J Cardiovasc Electrophysiol. 2005 Jul;16(7):732-9.

PMID:
16050831
18.

Wernicke encephalopathy.

Squirrell D, Shipman T, Rennie I.

Arch Ophthalmol. 2004 Mar;122(3):418-9. No abstract available.

PMID:
15006870
20.

Surgical correction of large-angle exotropia in adults.

Currie ZI, Shipman T, Burke JP.

Eye (Lond). 2003 Apr;17(3):334-9.

PMID:
12724695
21.

In vivo role of truncated trkb receptors during sensory ganglion neurogenesis.

Luikart BW, Nef S, Shipman T, Parada LF.

Neuroscience. 2003;117(4):847-58.

PMID:
12654337
22.

Neurotrophins are not required for normal embryonic development of olfactory neurons.

Nef S, Lush ME, Shipman TE, Parada LF.

Dev Biol. 2001 Jun 1;234(1):80-92.

23.

A molecular basis for estrogen-induced cryptorchidism.

Nef S, Shipman T, Parada LF.

Dev Biol. 2000 Aug 15;224(2):354-61.

24.

Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators.

Grubman EM, Pavri BB, Shipman T, Britton N, Kocovic DZ.

J Am Coll Cardiol. 1998 Oct;32(4):1056-62.

25.

Convergence insufficiency in thyroid eye disease.

Burke JP, Shipman TC, Watts MT.

J Pediatr Ophthalmol Strabismus. 1993 Mar-Apr;30(2):127-9.

PMID:
8501618
26.

Long-term outcome with the automatic implantable cardioverter-defibrillator.

Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T.

J Am Coll Cardiol. 1989 May;13(6):1353-61.

27.

Scientific adventuring and misadventures. LA-3827-MS.

Shipman TL, Reider R.

LA Rep. 1966 Jul 18:3-8. No abstract available.

PMID:
4869891
28.

[Can you answer patients' questions about radiation].

SHIPMAN TL.

J Mich State Med Soc. 1959 Apr;58(4):608-10 passim. Undetermined Language. No abstract available.

PMID:
13642007
29.

Administrative problems in nuclear energy.

SHIPMAN TL.

AMA Arch Ind Health. 1958 Aug;18(2):106-9. No abstract available.

PMID:
13558724
30.

Use of calcium ethylenediaminetetraacetate in cases of lead intoxication.

FOREMAN H, HARDY HL, SHIPMAN TL, BELKNAP EL.

AMA Arch Ind Hyg Occup Med. 1953 Feb;7(2):148-51. No abstract available.

PMID:
13007210
31.

The relation between the industrial physician and the family doctor.

SHIPMAN TL.

N Engl J Med. 1948 Oct 21;239(17):615-9. No abstract available.

PMID:
18888803

Supplemental Content

Loading ...
Support Center